Dopamine agonist bromocriptine for the prevention of ovarian hyperstimulation syndrome.
The aim of this retrospective study is to investigate the frequency and severity of ovarian hyperstimulation syndrome and the pregnancy rate in a patient collective at risk who received bromocriptine treatment.